Lipocalin overexpression to the resistance to apoptosis of tumor b cells in chronic

HIGHLIGHTS

• who: CLL and collaborators from the (UNIVERSITY) have published the article: Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic, in the Journal: Cancers 2020, 2124 of /2020/
• what: Using a FITC-conjugated anti-SLC22A17, the authors show that only a very small proportion of normal PBMCs expressed NGAL-R . This study provides evidence that NGAL may have a diagnostic value in untreated CLL and a predictive value in patients in remission; in addition, the findings strongly suggest the involvement of NGAL in the resistance to apoptosis of neoplastic CLL cells . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.